Psyence Group Inc. (PSYGD)
OTCMKTS · Delayed Price · Currency is USD
0.1165
0.00 (0.00%)
Jul 17, 2025, 4:00 PM EDT

Psyence Group Company Description

Psyence Group Inc., a life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom.

It operates in two segments: Clinical Trial Activities and Non-Clinical Trial Activities. The company natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions.

It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand.

The company was founded in 2019 and is based in Toronto, Canada.

Psyence Group Inc.
CountryCanada
Founded2019
IndustryDrug Manufacturers - General
SectorHealthcare

Contact Details

Address:
121 Richmond Street West
Toronto, Ontario M5H 2K1
Canada
Phone416-477-1708
Websitepsyence.com

Stock Details

Ticker SymbolPSYGD
ExchangeOTCMKTS
Fiscal YearApril - March
Reporting CurrencyCAD
SIC Code2836

Key Executives

NamePosition
Jody AufrichtigCo-Founder and Executive Chairman
Adri BothaInterim Chief Financial Officer
Taryn VosGeneral Counsel
Tony BuddenChief Strategy Officer
Mary-Elizabeth GiffordExecutive Vice President for Public Policy and Global Impact